Tirofiban Strategy
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to basket failed.
Please try again later
Add to wishlist failed.
Please try again later
Remove from wishlist failed.
Please try again later
Adding to library failed
Please try again
Follow podcast failed
Unfollow podcast failed
Tirofiban Strategy
-
Narrated by:
-
By:
Summary
Branch atheromatous disease (BAD)-related stroke patients have the risk of early neurological deterioration (END) with disability. The efficacy and safety of intensive antiplatelet therapy using intravenous tirofiban combined with aspirin in this population remain unclear.
adbl_web_anon_alc_button_suppression_c
No reviews yet